Urological complications of illicit drug use

Nature Reviews Urology

Volumn 11, Issue 3, 2014, Pages 169-177

  Skeldon, Sean C ^a   Goldenberg, S Larry ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; BUPRENORPHINE; CANNABIS; CLOMIFENE CITRATE; COCAINE; DIAMORPHINE; EPHEDRINE; ESTROGEN RECEPTOR; GUAIFENESIN; ILLICIT DRUG; KETAMINE; LUTEINIZING HORMONE; METHADONE; METHAMPHETAMINE; PSEUDOEPHEDRINE; TESTOSTERONE;

ACUTE KIDNEY FAILURE; ANOREXIA; BLADDER CANCER; CANCER RISK; CANNABIS USE; DRUG ABUSE; ERECTILE DYSFUNCTION; FOURNIER GANGRENE; GENITAL HERPES; GLAUCOMA; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; KIDNEY CANCER; KIDNEY INFARCTION; LOWER URINARY TRACT SYMPTOM; NEUROPATHIC PAIN; NOCTURNAL ENURESIS; PREMATURE EJACULATION; PRIAPISM; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHABDOMYOLYSIS; SMOKING; TESTOSTERONE BLOOD LEVEL; URINARY TRACT DISEASE; URINE RETENTION;

FOURNIER GANGRENE; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; PROSTATIC NEOPLASMS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; URINARY BLADDER NEOPLASMS; UROLOGIC DISEASES;

EID: 84897111112     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2014.22     Document Type: Review

References (149)

1. Home Office. Drug Misuse Declared: Findings from the 2011/12 Crime Survey for England and Wales [online], https://www.gov.uk/government/publications/ drug-misuse-declared-findings-from-the-2011-to-2012-crime-survey-for-england- and-wales-csew-second-edition (2012
2. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health, 2011 [online], http://www.icpsr.umich.edu/ icpsrweb/SAMHDA/studies/34481/version/2 (2011
3. Hwang, S. W. Homelessness and health. CMAJ 164, 229-233 (2001
4. US Department of Housing and Urban Development. The 2010 Annual Homeless Assessment Report to Congress [online], https://www.onecpd.info/resources/ documents/2010homelessassessmentreport.pdf (2011
5. Christin, N. Traveling the Silk Road: A measurement analysis of a large anonymous online marketplace. arXiv arXiv1207.7139 (2012
6. Devlin, R. J. & Henry, J. A. Clinical review: Major consequences of illicit drug consumption. Crit. Care 12, 202 (2008
7. Coull, N. & OBrien, T. Street urology: Beyond the formulary. BJU Int. 103, 721-722 (2009
8. Forster, J. A. & Harrison, S. C. Ketamine uropathy: Rising to the challenges of a new condition. BJU Int. 109, 1277-1278 (2012
9. Fronczak, C. M., Kim, E. D. & Barqawi, A. B. The insults of illicit drug use on male fertility. J. Androl. 33, 515-528 (2012
10. Hall, W. & Degenhardt, L. Adverse health effects of non-medical cannabis use. Lancet 374, 1383-1391 (2009
11. Trabert, B., Sigurdson, A. J., Sweeney, A. M., Strom, S. S. & McGlynn, K. A. Marijuana use and testicular germ cell tumors. Cancer 117, 848-853 (2011
12. Vescovi, P. P. et al. Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend. 30, 59-63 (1992
13. Shamloul, R. & Bella, A. J. Impact of cannabis use on male sexual health. J. Sex. Med. 8, 971-975 (2011
14. Lacson, J. C. et al. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer 118, 5374-5383 (2012
15. Smith, A. M. et al. Cannabis use and sexual health. J. Sex. Med. 7, 787-793 (2010
16. Johnson, S. D., Phelps, D. L. & Cottler, L. B. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch. Sex. Behav. 33, 55-63 (2004
17. Aversa, A. et al. Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int. J. Impot. Res. 20, 566-573 (2008
18. Castelli, M. P. et al. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: Immunocytochemistry, autoradiography and behavioral studies. Neuroscience 147, 197-206 (2007
19. Gratzke, C., Christ, G. J., Stief, C. G., Andersson, K.-E. & Hedlund, P. Localization and function of cannabinoid receptors in the corpus cavernosum: Basis for modulation of nitric oxide synthase nerve activity. Eur. Urol. 57, 342-348 (2010
20. Bowles, D. W., OBryant, C. L., Camidge, D. R. & Jimeno, A. The intersection between cannabis and cancer in the United States. Crit. Rev. Oncol. Hematol. 83, 1-10 (2012
21. Chacko, J. A, Heiner, J. G., Siu, W., Macy, M. & Terris, M. K. Association between marijuana use and transitional cell carcinoma. Urology 67, 100-104 (2006).
22. Sidney, S., Quesenberry, C. P., Friedman, G. D. & Tekawa, I. S. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 8, 722-728 (1997
23. Daling, J. R. et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115, 1215-1223 (2009
24. Hoffmann, D. E. & Weber, E. Medical marijuana and the law. N. Engl. J. Med. 362, 1453-1457 (2010
25. Baker, D., Pryce, G., Giovannoni, G. & Thompson, A. J. The therapeutic potential of cannabis. Lancet Neurol. 2, 291-298 (2003
26. Wade, D. T., Robson, P., House, H., Makela, P. & Aram, J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin. Rehabil. 17, 21-29 (2003
27. Freeman, R. M. et al. The effect of cannabis on urge incontinence in patients with multiple sclerosis: A multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int. Urogynecol. J. Pelvic Floor Dysfunct. 17, 636-641 (2006
28. Kavia, R. B. C., De Ridder, D., Constantinescu, C. S., Stott, C. G. & Fowler, C. J. Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult. Scler. 16, 1349-1359 (2010
29. Martin, R. S. et al. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Br. J. Pharmacol. 129, 1707-1715 (2000
30. Capasso, R. et al. Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility. Urology 77, 1006.e9-1006.e15 (2011
31. Burton, T. A. Urinary retention following cannabis ingestion. JAMA 242, 351 (1979
32. Warner, E. A. Cocaine abuse. Ann. Intern. Med. 119, 226-235 (1993
33. Zimmerman, J. L. Cocaine intoxication. Crit. Care Clin. 28, 517-526 (2012
34. Fabbian, F. et al. Left kidney: An unusual site of cocaine-related renal infarction. A case report. Eur. Rev. Med. Pharmacol. Sci. 16 (Suppl. 1), 30-33 (2012
35. Madhrira, M. M., Mohan, S., Markowitz, G. S., Pogue, V. A. & Cheng, J.-T. Acute bilateral renal infarction secondary to cocaine-induced vasospasm. Kidney Int. 76, 576-580 (2009
36. Hoefsloot, W., de Vries, R. A., Bruijnen, R. & Bosch, F. H. Renal infarction after cocaine abuse: A case report and review. Clin. Nephrol. 72, 234-236 (2009
37. Bemanian, S., Motallebi, M. & Nosrati, S. M. Cocaine-induced renal infarction: Report of a case and review of the literature. BMC Nephrol. 6, 10 (2005
38. Jaffe, J. A. & Kimmel, P. L. Chronic nephropathies of cocaine and heroin abuse: A critical review. Clin. J. Am. Soc. Nephrol. 1, 655-667 (2006
39. Mireku-Boateng, A. O. & Tasie, B. Priapism associated with intracavernosal injection of cocaine. Urol. Int. 67, 109-110 (2001
40. Khan, F. et al. Fourniers gangrene associated with intradermal injection of cocaine. J. Sex. Med. 10, 1184-1186 (2013
41. Chan, J. Y., Huang, C. L. & Chan, S. H. Nitric oxide as a mediator of cocaine-induced penile erection in the rat. Br. J. Pharmacol. 118, 155-161 (1996
42. Munarriz, R., Hwang, J., Goldstein, I., Traish, A. M. & Kim, N. N. Cocaine and ephedrine-induced priapism: Case reports and investigation of potential adrenergic mechanisms. Urology 62, 187-192 (2003
43. Roberts, J. R., Price, C. & Mazzeo, T. Intracavernous epinephrine: A minimally invasive treatment for priapism in the emergency department. J. Emerg. Med. 36, 285-289 (2009
44. Altman, A. L., Seftel, A. D., Brown, S. L. & Hampel, N. Cocaine associated priapism. J. Urol. 161, 1817-1818 (1999
45. Fiorelli, R. L., Manfrey, S. J., Belkoff, L. H. & Finkelstein, L. H. Priapism associated with intranasal cocaine abuse. J. Urol. 143, 584-585 (1990
46. Mouraviev, V. B., Pautler, S. E. & Hayman, W. P. Fourniers gangrene following penile self-injection with cocaine. Scand. J. Urol. Nephrol. 36, 317-318 (2002
47. Carey, F. & Dinsmore, W. W. Cocaine-induced penile necrosis. Int. J. STD AIDS 15, 424-425 (2004
48. Chen, S.-C. et al. Cocaine-related vasculitis causing scrotal gangrene. Ann. Pharmacother. 43, 375-378 (2009
49. Kalant, H. The pharmacology and toxicology of ecstasy (MDMA) and related drugs. CMAJ 165, 917-928 (2001
50. Mellemgaard, A. et al. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int. J. Cancer 60, 350-354 (1995
51. Lindblad, P., Wolk, A., Bergstrm, R., Persson, I. & Adami, H. O. The role of obesity and weight fluctuations in the etiology of renal cell cancer: A population-based case-control study. Cancer Epidemiol. Biomarkers Prev. 3, 631-639 (1994
52. Yu, M. C., Mack, T. M., Hanisch, R., Cicioni, C. & Henderson, B. E. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J. Natl Cancer Inst. 77, 351-356 (1986
53. Yuan, J. M., Castelao, J. E., Gago-Dominguez, M., Ross, R. K. & Yu, M. C. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br. J. Cancer 77, 1508-1513 (1998
54. Dunnick, J. K. & Eustis, S. L. Decreases in spontaneous tumors in rats and mice after treatment with amphetamine. Toxicology 67, 325-332 (1991
55. Campbell, G. A. & Rosner, M. H. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin. J. Am. Soc. Nephrol. 3, 1852-1860 (2008
56. Richards, J. R., Johnson, E. B., Stark, R. W. & Derlet, R. W. Methamphetamine abuse and rhabdomyolysis in the ED: A 5-year study. Am. J. Emerg. Med. 17, 681-685 (1999
57. Cartledge, J. J., Chow, W. M. & Stewart, P. A. Acute renal failure after amphetamine presenting with loin pain. Br. J. Urol. 81, 160-161 (1998
58. Sultana, S. R. & Byrne, D. J. Ravers haematuria. J. R. Coll. Surg. Edinb. 41, 419-420 (1996
59. Shannon, M. Methylenedioxymethamphetamine (MDMA, Ecstasy). Pediatr. Emerg. Care 16, 377-380 (2000
60. Beuerle, J. R. & Barrueto, F. J. Neurogenic bladder and chronic urinary retention associated with MDMA abuse. J. Med. Toxicol. 4, 106-108 (2008
61. Delgado, J. H., Caruso, M. J., Waksman, J. C., Honigman, B. & Stillman, D. Acute, transient urinary retention from combined ecstasy and methamphetamine use. J. Emerg. Med. 26, 173-175 (2004
62. Bryden, A. A., Rothwell, P. J. & OReilly, P. H. Urinary retention with misuse of ecstasy. BMJ 310, 504 (1995
63. Inman, D. S. & Greene, D. The agony and the ecstasy: Acute urinary retention after MDMA abuse. BJU Int. 91, 123 (2003
64. Worsey, J., Goble, N. M., Stott, M. & Smith, P. J. Bladder outflow obstruction secondary to intravenous amphetamine abuse. Br. J. Urol. 64, 320-321 (1989
65. Bennett, A. H. & Delrio, A. Idiopathic rupture of the bladder: Association with methamphetamine and alcohol. J. Urol. 124, 429-430 (1980
66. Schwartz, D. T. Idiopathic rupture of the bladder. J. Urol. 125, 602 (1981
67. Deshpande, A. V., Caldwell, P. H. Y. & Sureshkumar, P. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database of Systematic Reviews, Issue Art. No.: CD002238. http://dx.doi.org/10.1002/14651858.CD002238 (2012
68. Andersen, M. L. et al. Association of paradoxical sleep deprivation and ecstasy (MDMA) enhances genital reflexes in male rats. Behav. Brain Res. 170, 287-292 (2006
69. Zemishlany, Z., Aizenberg, D. & Weizman, A. Subjective effects of MDMA (Ecstasy) on human sexual function. Eur. Psychiatry 16, 127-130 (2001
70. Bang-Ping, J. Sexual dysfunction in men who abuse illicit drugs: A preliminary report. J. Sex. Med. 6, 1072-1080 (2009
71. Bloor, R. N. Whizz-dick: Side effect, urban myth or amfetamine-related koro-like syndrome Int. J. Clin. Pract. 58, 717-719 (2004
72. Foley, C. L. & Bycroft, J. Street urology: Beyond the formulary. BJU Int. 104, 722 (2009
73. Colfax, G. & Guzman, R. Club drugs and HIV infection: A review. Clin. Infect. Dis. 42, 1463-1469 (2006
74. Freeman, P. et al. Methamphetamine use and risk for HIV among young men who have sex with men in 8 US cities. Arch. Pediatr. Adolesc. Med. 165, 736-740 (2011
75. Fisher, D. G., Reynolds, G. L. & Napper, L. E. Use of crystal methamphetamine, Viagra, and sexual behavior. Curr. Opin. Infect. Dis. 23, 53-56 (2010
76. Zule, W. A, Costenbader, E. C., Meyer, W. J. & Wechsberg, W. M. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sex. Transm. Dis. 34, 689-694 (2007
77. Valencia, F., Bubar, M. J., Milligan, G., Cunningham, K. A. & Bourne, N. Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model. Sex. Transm. Dis. 39, 720-725 (2012
78. Pennock, J. W. et al. 3,4-Methylenedioxymethamphetamine increases susceptibility to genital herpes simplex virus infection in mice. J. Infect. Dis. 200, 1247-1250 (2009
79. Gahr, M., Plener, P. L., Klle, M. A., Freudenmann, R. W. & Schnfeldt-Lecuona, C. Self-mutilation induced by psychotropic substances: A systematic review. Psychiatry Res. 200, 977-983 (2012
80. Israel, J. A. & Lee, K. Amphetamine usage and genital self-mutilation. Addiction 97, 1215-1218 (2002
81. Crowe, A. V., Howse, M., Bell, G. M. & Henry, J. A. Substance abuse and the kidney. QJM 93, 147-152 (2000
82. Kosten, T. R. & OConnor, P. G. Management of drug and alcohol withdrawal. N. Engl. J. Med. 348, 1786-1795 (2003
83. Kleber, H. D. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA 300, 2303-2305 (2008
84. La Pera, G. et al. Sexual dysfunction prior to first drug use among former drug addicts and its possible causal meaning on drug addiction: Preliminary results. J. Sex. Med. 5, 164-172 (2008).
85. Chen, W. et al. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China. J. Addict. Med. 6, 212-218 (2012
86. Quaglio, G. et al. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend. 94, 12-18 (2008
87. Hallinan, R. et al. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J. Sex. Med. 5, 684-692 (2008
88. Bliesener, N. et al. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J. Clin. Endocrinol. Metab. 90, 203-206 (2005
89. Quaglio, G. et al. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend. 94, 12-18 (2008
90. Mirin, S. M., Meyer, R. E., Mendelson, J. H. & Ellingboe, J. Opiate use and sexual function. Am. J. Psychiatry 137, 909-915 (1980
91. Wang, C., Chan, V. & Yeung, R. T. The effect of heroin addiction on pituitary-testicular function. Clin. Endocrinol. (Oxf.). 9, 455-461 (1978
92. Chekuri, V., Gerber, D., Brodie, A. & Krishnadas, R. Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addict. Behav. 37, 124-126 (2012
93. Al-Gommer, O., George, S., Haque, S., Moselhy, H. & Saravanappa, T. Sexual dysfunctions in male opiate users: A comparative study of heroin, methadone, and buprenorphine. Addict. Disord. Their Treat. 6, 137-143 (2007
94. Mintz, J., OHare, K., OBrien, C. P. & Goldschmidt, J. Sexual problems of heroin addicts. Arch. Gen. Psychiatry 31, 700-703 (1974
95. Abdollahian, E. et al. Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification. Am. J. Addict. 15, 100-104 (2006
96. Somers, W. J. & Lowe, F. C. Localized gangrene of the scrotum and penis: A complication of heroin injection into the femoral vessels. J. Urol. 136, 111-113 (1986
97. Alguire, P. C. Necrotizing cellulitis of the scrotum: A new complication of heroin addiction. Cutis 34, 93-95 (1984
98. Winek, C. L., Wahba, W. W. & Rozin, L. Heroin fatality due to penile injection. Am. J. Forensic Med. Pathol. 20, 90-92 (1999
99. White, W. B. & Barrett, S. Penile ulcer in heroin abuse: A case report. Cutis 29, 62-69 (1982
100. Aliasgari, M. A., Kaviani, A., Gachkar, L. & Hosseini-Nassab, S. R. Is bladder cancer more common among opium addicts Urol. J. 1, 253-255 (2004
101. Shakhssalim, N. et al. Prominent bladder cancer risk factors in Iran. Asian Pac. J. Cancer Prev. 11, 601-606 (2010
102. Hosseini, S. Y., Safarinejad, M. R., Amini, E. & Hooshyar, H. Opium consumption and risk of bladder cancer: A case-control analysis. Urol. Oncol. 28, 610-616 (2010
103. Shahani, R., Streutker, C., Dickson, B. & Stewart, R. J. Ketamine-associated ulcerative cystitis: A new clinical entity. Urology 69, 810-812 (2007
104. Winstock, A. R., Mitcheson, L., Gillatt, D. A. & Cottrell, A. M. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 110, 1762-1766 (2012
105. Morgan, C. J. A. & Curran, H. V. Ketamine use: A review. Addiction 107, 27-38 (2012
106. Jang, M.-Y. et al. Sexual dysfunction in women with ketamine cystitis: A case-control study. BJU Int. 110, 427-431 (2012
107. Middela, S. & Pearce, I. Ketamine-induced vesicopathy: A literature review. Int. J. Clin. Pract. 65, 27-30 (2011
108. Mak, S. K. et al. Lower urinary tract changes in young adults using ketamine. J. Urol. 186, 610-614 (2011
109. Meng, E. et al. Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction. J. Urol. 186, 1134-1141 (2011
110. Chu, P. S.-K. et al. The destruction of the lower urinary tract by ketamine abuse: A new syndrome BJU Int. 102, 1616-1622 (2008
111. Huang, P.-W. et al. Walking-stick ureters in ketamine abuse. Kidney Int. 80, 895 (2011
112. Oxley, J. D., Cottrell, A. M., Adams, S. & Gillatt, D. Ketamine cystitis as a mimic of carcinoma in situ. Histopathology 55, 705-708 (2009
113. Lai, Y. et al. Ketamine-associated urinary tract dysfunction: An underrecognized clinical entity. Urol. Int. 89, 93-96 (2012
114. Wu, S. et al. Lower urinary tract destruction due to ketamine: A report of 4 cases and review of literature. J. Addict. Med. 6, 85-88 (2012
115. Chao, J.-Y. & Shai, H.-A. Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: A case report. Gen. Hosp. Psychiatry 32, 647.e5-647.e6 (2010
116. Chen, J.-L. et al. Renal infarction secondary to ketamine abuse. Am. J. Emerg. Med. 31, 1153.e3-1153.e5 (2013
117. Evans, N. A. Current concepts in anabolic-androgenic steroids. Am. J. Sports Med. 32, 534-542 (2004
118. Di Luigi, L., Romanelli, F., Sgr, P. & Lenzi, A. Andrological aspects of physical exercise and sport medicine. Endocrine 42, 278-284 (2012
119. Johnston, L., OMalley, P., Bachman, J. & Schulenberg, J. The rise in teen marijuana use stalls, synthetic marijuana use levels, and use of bath salts is very low. University of Michigan News Service [online], http://ns.umich.edu/ new/releases/21042-rise-in-teen-marijuana-use-stalls-use-of-synthetic-marijuana- and-bath-salts-is-very-low (2012
120. Kanayama, G., Brower, K. J., Wood, R. I., Hudson, J. I. & Pope, H. G. Anabolic-androgenic steroid dependence: An emerging disorder. Addiction 104, 1966-1978 (2009
121. Tan, R. S. & Vasudevan, D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil. Steril. 79, 203-205 (2003
122. Tan, R. S. & Scally, M. C. Anabolic steroid-induced hypogonadism-towards a unified hypothesis of anabolic steroid action. Med. Hypotheses 72, 723-728 (2009
123. Bickelman, C., Ferries, L. & Eaton, R. P. Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate. West. J. Med. 162, 158-160 (1995
124. Coward, R. M. et al. Anabolic steroid induced hypogonadism in young men. J. Urol. 190, 2200-2205 (2013
125. Tan, R. S. & Vasudevan, D. Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. Fertil. Steril. 79, 203-205 (2003
126. Goldberg, L. Adverse effects of anabolic steroids. JAMA 276, 257 (1996
127. Roberts, J. T. & Essenhigh, D. M. Adenocarcinoma of prostate in 40-year-old body-builder. Lancet 2, 742 (1986
128. Vogelzang, N. J., Arnold, J. L., Chodak, G. J. & Schoenberg, H. Androgen and germ cell testicular cancers. JAMA 255, 906 (1986
129. Pinto, F. et al. Doping and urologic tumors [Italian]. Urologia 77, 92-99 (2010
130. Bronson, F. H. & Matherne, C. M. Exposure to anabolic-androgenic steroids shortens life span of male mice. Med. Sci. Sports Exerc. 29, 615-619 (1997
131. Martorana, G., Concetti, S., Manferrari, F. & Creti, S. Anabolic steroid abuse and renal cell carcinoma. J. Urol. 162, 2089 (1999
132. Bryden, A. A., Rothwell, P. J. & OReilly, P. H. Anabolic steroid abuse and renal-cell carcinoma. Lancet 346, 1306-1307 (1995
133. Wemyss-Holden, S. A., Hamdy, F. C. & Hastie, K. J. Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction-is there a relationship Br. J. Urol. 74, 476-478 (1994
134. Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products-Texas, December 1993-September 1995. JAMA 276, 1711-1712 (1996
135. Broadley, K. J. The vascular effects of trace amines and amphetamines. Pharmacol. Ther. 125, 363-375 (2010
136. Song, G. Y., Lockhart, M. E., Smith, J. K., Burns, J. R. & Kenney, P. J. Pseudoephedrine and guaifenesin urolithiasis: widening the differential diagnosis of radiolucent calculi on abdominal radiograph. Abdom. Imaging 30, 644-646 (2005
137. Powell, T., Hsu, F. F., Turk, J. & Hruska, K. Ma-huang strikes again: Ephedrine nephrolithiasis. Am. J. Kidney Dis. 32, 153-159 (1998
138. Pickens, C. L. et al. Abuse of guaifenesin-containing medications generates an excess of a carboxylate salt of beta-(2-methoxyphenoxy)-lactic acid, a guaifenesin metabolite, and results in urolithiasis. Urology 54, 23-27 (1999
139. Blau, J. J. Ephedrine nephrolithiasis associated with chronic ephedrine abuse. J. Urol. 160, 825 (1998
140. Hoffman, N., McGee, S. M. & Hulbert, J. C. Resolution of ephedrine stones with dissolution therapy. Urology 61, 1035 (2003
141. Whelan, C. & Schwartz, B. F. Bilateral guaifenesin ureteral calculi. Urology 63, 175-176 (2004
142. Smith, C. L., Gemar, S. K. & Lewis, M. J. Pseudoephedrine urolithiasis associated with acute renal failure. Nephrol. Dial. Transplant. 19, 263-264 (2004
143. Assimos, D. G. et al. Guaifenesin-and ephedrine-induced stones. J. Endourol. 13, 665-667 (1999
144. Bennett, S., Hoffman, N. & Monga, M. Ephedrine-and guaifenesin-induced nephrolithiasis. J. Altern. Complement. Med. 10, 967-969 (2004
145. Abedin Zadeh, M., Moslemi, M. K. & Kholaseh Zadeh, G. Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: A double-blind clinical trial. J. Pediatr. Urol. 7, 30-33 (2011
146. El Hemaly, A. K. Nocturnal enuresis: Pathogenesis and treatment. Int. Urogynecol. J. Pelvic Floor Dysfunct. 9, 129-131 (1998
147. Glidden, R. S. & DiBona, F. J. Urinary retention associated with ephedrine. J. Pediatr. 90, 1013-1014 (1977
148. Soyer, T., Gl, I. H., Eroglu, F. & Cetin, A. Acute urinary retention due to pseudoephedrine hydrochloride in a 3-year-old child. Turk. J. Pediatr. 50, 98-100 (2008
149. Zorgniotti, A. W., Rossman, B. & Claire, M. Possible role of chronic use of nasal vasoconstrictors in impotence. Urology 30, 594 (1987).